StimCell Enegetics Inc
OTC:STME
StimCell Enegetics Inc
OTC:STME
Price:
0.286
USD
-4.7%
Market Closed
Market Cap:
$6m
Balance Sheet
Balance Sheet Decomposition
StimCell Enegetics Inc
StimCell Enegetics Inc
Balance Sheet Decomposition is not available for
StimCell Enegetics Inc
StimCell Enegetics Inc
Balance Sheet
StimCell Enegetics Inc
StimCell Enegetics Inc
Currency: USD
| May-2010 | May-2011 | May-2012 | May-2013 | May-2014 | May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | May-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
-50%
|
0
N/A
|
0
N/A
|
0
+477%
|
0
+9%
|
0
-85%
|
0
+321%
|
0
-16%
|
0
-67%
|
0
-21%
|
0
+150%
|
0
-55%
|
0
-54%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
1
+3 553%
|
2
+130%
|
1
-13%
|
1
-24%
|
2
+75%
|
2
-14%
|
2
-3%
|
2
+26%
|
2
+21%
|
1
-65%
|
1
+45%
|
|
| Equity | |||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
6
|
7
|
8
|
9
|
9
|
10
|
10
|
10
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
5
|
5
|
6
|
7
|
7
|
7
|
9
|
9
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
-3 321%
|
1
-106%
|
1
+17%
|
1
+8%
|
2
-65%
|
2
+14%
|
2
-4%
|
2
-27%
|
2
-19%
|
1
+65%
|
1
-51%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
-50%
|
0
N/A
|
0
N/A
|
0
+477%
|
0
+9%
|
0
-85%
|
0
+321%
|
0
-16%
|
0
-67%
|
0
-21%
|
0
+150%
|
0
-55%
|
0
-54%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
30
|
30
|
31
|
31
|
31
|
31
|
31
|
40
|
44
|
44
|
56
|
62
|
4
|
4
|
20
|
20
|
|
Switch to:
Switch to:
See Also
Discover More
